John Fung to Liver Diseases
This is a "connection" page, showing publications John Fung has written about Liver Diseases.
Connection Strength
1.334
-
Dental health status of liver transplant candidates. Liver Transpl. 2007 Feb; 13(2):280-6.
Score: 0.257
-
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl. 2003 Sep; 9(9):954-60.
Score: 0.203
-
Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg. 2000 Feb; 35(2):283-9; discussion 289-90.
Score: 0.158
-
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg. 1996 Aug; 183(2):117-25.
Score: 0.124
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.104
-
Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006 Aug; 30(8):986-93.
Score: 0.062
-
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation. 2003 Sep 15; 76(5):827-32.
Score: 0.051
-
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol. 2002 Sep; 37(3):340-8.
Score: 0.047
-
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol. 2001 Mar; 41(3):268-76.
Score: 0.043
-
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression. Ann Transplant. 2018 Oct 26; 23:751-757.
Score: 0.036
-
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation. 1998 Feb 27; 65(4):499-504.
Score: 0.035
-
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. Liver Transpl Surg. 1997 Nov; 3(6):594-7.
Score: 0.034
-
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol. 1995 Feb; 19(2):192-206.
Score: 0.028
-
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994 Jul; 20(1 Pt 2):56S-62S.
Score: 0.027
-
Liver transplantation under cyclosporine: a decade of experience. Transplant Proc. 1991 Feb; 23(1 Pt 2):1393-6.
Score: 0.021
-
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc. 1990 Feb; 22(1):57-9.
Score: 0.020
-
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc. 1990 Feb; 22(1):6-12.
Score: 0.020
-
Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988 Aug; 208(2):196-202.
Score: 0.018
-
Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
Score: 0.011
-
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation. 1997 Sep 15; 64(5):786-8.
Score: 0.008
-
The patient with chronic hepatitis C. Liver Transpl Surg. 1996 Sep; 2(5 Suppl 1):73-8.
Score: 0.008
-
Prioritization and organ distribution for liver transplantation. JAMA. 1994 Jan 12; 271(2):140-3.
Score: 0.007
-
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
Score: 0.006
-
The liver transplant waiting list--a single-center analysis. Transplantation. 1991 Jan; 51(1):128-34.
Score: 0.005